Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 322-335

  Kuchler, Thomas ^a   Henne Bruns, Doris ^a   Rappat, Stefanie ^b   Graul, Joachim ^b   Holst, Karin ^b   Williams, J Ivan ^c   Wood Dauphinee, Sharon ^d  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Psychotherapy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PSYCHOTHERAPY; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0033000770     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1 Derogatis L, Morrow GR, Fetting J, et al: The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249:751-757.
2. 2 Holland J, Rowland JH (Eds.): Handbook of psychooncology - psychological care of the patient with cancer. New York, Oxford: Oxford University Press, 1989.
3. 3 Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO: Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 1995; 52:100-113.
4. 4 Spiegel D: Essentials of psychotherapeutic intervention for cancer patients. Support Care Cancer 1995; 3:252-256.
5. 5 Fox B: The role of psychological factors in cancer incidence and prognosis. Oncology 1995; 9:245-253.
6. 6 Forester B, Kornfeld DS, Fleiss JL: Psychotherapy during radiotherapy: effects on emotional and physical distress. Am J Psychiatry 1985; 142:22-27.
7. 7 Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365-376.
8. 8 Cohen J; Statistical power analysis for the behavioral sciences. 2nd Edition. New Jersey, London: Lawrence Erlbaum Associates, 1988; pp. 48-51.
9. 9 Greer S, Moorey S, Watson M: Patients adjustment to cancer: The Mental Adjustment to Cancer (MAC) Scale vs. clinical ratings. J Psychosomat Res 1989; 33:373-377.
10. 10 Haljamae H: Anesthetic risk factors. Acta Chir Scand 1988; Suppl 550:11-21.
11. 11 Hermanek P, Henson DE, Hutter RVP, Sobin LH (Editors): UICC TNM Supplement 1993: A commentary on uniform use. New York: Springer Verlag, 1993.
12. 12 Hermanek P, Sobin LH (Editors): UICC TNM Classification of Malignant Tumors. 4th Edition. New York: Springer Verlag, 1987.
13. 13 Eddy DM: Evaluating medical technologies. In: Spilker B (Ed.). Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996; pp. 761-771.
14. 14 Hermanek P: pTNM and Residual Tumor Classifications: problems of assessment and prognostic significance. World J Surg 1995; 19:184-190.
15. 15 Spiegel D, Bloom JR, Kraemer HC, Gottheil E: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; II:888-891.
16. 16 Fawzy FI, Fawzy N, Hyuns P, et al: Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival six years later. Arch Gen Psychiatry 1990; 50:681-689.
17. 17 Richardson JL, Shelton DR, Krailo M, Levine AM: The effect of compliance with treatment on survival among patients with hematological malignancies. J Clin Oncol 1990; 8:356-364.
18. 18 Linn MW, Linn BS, Harris R: A randomized control trial of psychotherapeutic intervention in cancer patients. Cancer 1982; 49:1048-1055.
19. 19 Ilnyckyi A, Farber J, Cheang MC, Weinerman BH: A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Physicians Surg Can 1994; 27:93-96.
20. 20 Gellert GA, Maxwell RM, Siegel BS: Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10 year follow-up study. J Clin Oncol 1993; 11:66-69.
21. 21 Classen C, Sephton SE, Diamond S, Spiegel D: Studies of life-extending psychosocial interventions. In: Holland J, Rowland JH (Eds.). Handbook of psychooncology - psychological care of the patient with cancer. New York, Oxford: Oxford University Press, 1989; pp. 731-742.
22. 22 Ader R, Felten D, Cohen N: Interaction between the brain and the immune system. Ann Rev Pharmacol Toxicol 1990; 30:561-602.
23. 23 Gruber BL, Hersh SP, Hall NRS, et al: Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul 1993; 18:1-21.
24. 24 Cunningham AJ, Lockwood GA, Edmonds CV: Which cancer patients benefit most from a brief, group, coping skills program? Int J Psychiatry Med 1993; 23:383-398.
25. 25 Thase ME, Reynolds CF, Frank E, et al: Do depressed men and women respond differently to cognitive behavior therapy? Am J Psychiatry 1994; 151:500-505.